Silverback Therapeutics, Inc.
NECTIN-4 ANTIBODY CONJUGATES AND USES THEREOF

Last updated:

Abstract:

The present disclosure provides conjugates of anti-Nectin-4 antibodies or antigen binding fragments thereof to a myeloid cell agonist, compositions comprising the conjugates, and methods of treating cancer with the conjugates. The present disclosure also provides for anti-Nectin-4 antibodies or antigen binding fragments thereof and method for using the antibodies or antigen binding fragments thereof in treating cancer.

Status:
Application
Type:

Utility

Filling date:

4 Oct 2021

Issue date:

7 Apr 2022